{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-031767","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2026-10-01T21:24:43+00:00","discovered_at":"2026-10-01T21:26:00.266972+00:00","generated_at":"2026-10-12T14:28:41.872945+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pyxis Oncology raises $102.8M in offering; common warrants need shareholder approval to be exercisable","bullets":["Sold 36,047,919 shares and 1,883,121 pre-funded warrants, each bundled with a common warrant for 1.3 shares, at a $2.90 combined price; offering closed October 1, 2026.","Common warrants have a $3.50 strike and cannot be exercised until stockholders approve a charter amendment raising authorized shares, via a special meeting within 60 days of closing.","Net proceeds were about $102.8 million; full cash exercise of all warrants would add roughly $162.2 million after a 6% solicitation fee to underwriters.","Cash plus offering proceeds fund operations into the first half of 2028, but without warrant exercise the funds will not fully cover the planned Phase 3 Headliner trial in 2L+ R/M HNSCC.","Proceeds go to advancing lead program MICVO; overall survival data from the Phase 1 monotherapy study is expected in the first half of 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-031767","json":"https://secwatch.observer/filing/0001437749-26-031767.json","markdown":"https://secwatch.observer/filing/0001437749-26-031767.md","text":"https://secwatch.observer/filing/0001437749-26-031767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/0001437749-26-031767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/pyxs20261001_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:28:41.872945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}